125 related articles for article (PubMed ID: 9207957)
1. Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma.
Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Shirakawa H; Ishibe T; Shirakawa R; Nagasaki M; Shirane T; Usui T
Prostate; 1997 Jun; 32(1):49-58. PubMed ID: 9207957
[TBL] [Abstract][Full Text] [Related]
2. Relationship of serum testosterone level with proliferating cell nuclear antigen and nm23 protein in human prostatic carcinoma tissue.
Shiina H; Igawa M; Shigeno K; Wada Y; Yoneda T; Yagi H; Shirakawa R; Nagasaki M
Oncology; 1997; 54(6):482-9. PubMed ID: 9394845
[TBL] [Abstract][Full Text] [Related]
3. Estramustine-binding protein to dihydrotestosterone ratio in human prostatic carcinoma: a new marker for predicting disease progression.
Shiina H; Igawa M; Ishibe T
Br J Urol; 1996 Jan; 77(1):96-101. PubMed ID: 8653325
[TBL] [Abstract][Full Text] [Related]
4. Estramustine-binding protein in carcinoma and benign hyperplasia of the human prostate.
Shiina H; Urakami S; Shirakawa H; Igawa M; Ishibe T; Usui T
Eur Urol; 1996; 29(1):106-10. PubMed ID: 8821700
[TBL] [Abstract][Full Text] [Related]
5. Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical study.
Flüchter SH; Nelde HJ; Björk P; Müntzing J; Bichler KH
Prostate; 1989; 14(1):27-43. PubMed ID: 2648345
[TBL] [Abstract][Full Text] [Related]
6. Clinical study on estramustine binding protein (EMBP) in human prostate.
Shiina H; Igawa M; Ishibe T
Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
8. Study of estramustine binding protein: its relationship to androgen dependency and histological differentiation in human prostatic carcinoma tissue.
Shiina H; Sumi H; Ishibe T; Usui T
Urol Int; 1994; 52(4):213-6. PubMed ID: 8030169
[TBL] [Abstract][Full Text] [Related]
9. Association of nm23 protein levels in human prostates with proliferating cell nuclear antigen expression at autopsy.
Igawa M; Urakami S; Shiina H; Ishibe T; Usui T; Chodak GW
Eur Urol; 1996; 30(3):383-7. PubMed ID: 8931974
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical technique for localization and semiquantitation of estramustine-binding protein (EMBP) in rat and human prostate.
Bichler KH; Flüchter SH; Nelde HJ; Björk P; Müntzing J
Prostate; 1989; 14(1):13-25. PubMed ID: 2467273
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
Br J Urol; 1995 Dec; 76(6):708-13. PubMed ID: 8535713
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of estramustine binding protein (EMBP) in prostatic intraepithelial neoplasia (PIN) compared with malignant and benign prostatic epithelia.
de la Torre M; Eklöv S; Häggman M; Björk P; Busch C; Nilsson S
Prostate; 1994 Sep; 25(3):125-31. PubMed ID: 7520576
[TBL] [Abstract][Full Text] [Related]
13. [Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].
Ji SQ; Hua YW; Zhuang J; Gao Y; Kong Y; Han SL; Shao YF
Ai Zheng; 2002 Jun; 21(6):619-24. PubMed ID: 12452062
[TBL] [Abstract][Full Text] [Related]
14. High levels of nm23 expression are related to cell proliferation in human prostate cancer.
Igawa M; Rukstalis DB; Tanabe T; Chodak GW
Cancer Res; 1994 Mar; 54(5):1313-8. PubMed ID: 8118821
[TBL] [Abstract][Full Text] [Related]
15. Estramustine binding protein (EMBP) in rat R3327 Dunning tumors: partial characterization and effect of hormonal withdrawal, hormonal replacement, and cytotoxic treatment on its expression.
Björk P; Isaacs JT; Hartley-Asp B
Prostate; 1991; 18(3):181-200. PubMed ID: 2020618
[TBL] [Abstract][Full Text] [Related]
16. Modal DNA values and estramustine-binding protein (EMBP) as prognostic markers in prostatic cancer.
Nordgren H; Nilsson S; Eklöv S; Stattin P; Naining W; Heiden T; Bergkvist L; Karlberg L; Lundholm C; Harvig B
Acta Oncol; 1991; 30(2):211-4. PubMed ID: 2029408
[TBL] [Abstract][Full Text] [Related]
17. Study of estramustine binding protein (EMBP): purification of rat EMBP and establishment of RIA.
Shiina H; Ishibe T; Usui T
Biochem Biophys Res Commun; 1989 Dec; 165(3):947-55. PubMed ID: 2482024
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
[TBL] [Abstract][Full Text] [Related]
19. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.
Konishi N; Nakaoka S; Tsuzuki T; Matsumoto K; Kitahori Y; Hiasa Y; Urano T; Shiku H
Jpn J Cancer Res; 1993 Oct; 84(10):1050-4. PubMed ID: 7693635
[TBL] [Abstract][Full Text] [Related]
20. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B
Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]